Global Expansion Hemanext has an exclusive distribution agreement with Hemara Bio in the UAE to expand sales across Gulf countries. This creates a clear path to regional hospital networks and procurement authorities in the GCC, supported by Hemara Bio's regional footprint and regulatory know-how. Leverage this partner to penetrate new accounts with bundled offerings that include blood processing, storage, and transfusion systems, along with localized service and installation capabilities.

Clinical Validation Data from a safety study was accepted for an oral presentation at the European Hematology Association 2025 Congress, signaling credible clinical validation for Hemanext's blood processing, storage and transfusion technology. Use these results to engage clinicians and procurement with evidence of safety improvements and potential patient outcomes, and consider targeted pilots in high-volume centers to demonstrate real-world value.

Strategic Partnerships Existing collaboration with Vitalant demonstrates readiness to work with large US blood centers, while the appointment of Geoff Crouse to the board adds governance credibility. These dynamics create openings to pursue additional large-center partnerships, co-development opportunities, and regional distributors, strengthening market access and multi-site studies.

Market Access ISO 13485 certification and a Massachusetts manufacturing footprint support global regulatory readiness and scalable service delivery. With R&D in Lexington and manufacturing in Avon, Hemanext can offer end-to-end support including installation, training and ongoing maintenance for hospital and blood-center deployments, aligning with transfusion optimization initiatives.

Growth Signals With revenue in the low to mid single-digit millions and notable funding activity in recent years plus leadership transition to a new CEO, Hemanext is positioned for accelerated expansion. There may be opportunities to engage through pilot funding, strategic co-investments, or grant programs with health systems and distributors, leveraging the company's growth trajectory to close large adoption deals.